Sia Daneshmand, MD - Putting Precision Into Practice for Bladder Cancer Treatment: Insights for Individualized Care Across the Disease Continuum

This content has been developed for healthcare professionals only.
Patients who seek health information should consult with their
physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides,
and complete CME/MOC/AAPA/IPCE information, and to apply for
credit, please visit us at PeerView.com/BYQ865. CME/MOC/AAPA/IPCE
credit will be available until May 27, 2026.


Putting Precision Into Practice for Bladder Cancer Treatment:
Insights for Individualized Care Across the Disease Continuum


In support of improving patient care, this activity has been
planned and implemented by PVI, PeerView Institute for Medical
Education, and Bladder Cancer Advocacy Network. PVI, PeerView
Institute for Medical Education, is jointly accredited by the
Accreditation Council for Continuing Medical Education (ACCME),
the Accreditation Council for Pharmacy Education (ACPE), and the
American Nurses Credentialing Center (ANCC), to provide
continuing education for the healthcare team.


SupportThis activity is supported by
independent educational grants from AstraZeneca, Daiichi Sankyo,
Inc., Ferring Pharmaceuticals, Inc., and Janssen Biotech, Inc.,
administered by Janssen Scientific Affairs, LLC (which are both
Johnson & Johnson companies).


Disclosure information is available at the beginning of the video
presentation.